Improving the Oversight and Monitoring of Psychotropic Medication Use - PowerPoint PPT Presentation

Improving the Oversight and Monitoring of Psychotropic Medication Use among Children in Medicaid September 11, 2015

Presentation Overview • Why Focus on Psychotropic Medication? • Behavioral Health Needs among Children and Youth • Psychotropic Medication Use and Expense in the Medicaid Child Population • Oversight and Monitoring – Defined • The Role of the System of Care • Key Strategies for an Effective Oversight and Monitoring System • TA Resources

The Issue • Concern regarding the use of psychotropic medications to address the behavioral health needs of children in Medicaid • Complexity of reaching consensus about “appropriate” use • Too many, too much, too young • Certain populations are of particular concern: • Very young children (ages 0 ‐ 3) • Transition age youth • Youth with substance use issues or co ‐ occurring mental health and substance use disorders • Children in foster care • Youth taking antipsychotic medications • Youth who experience trauma

Landmark Federal Communication “The Department of Health and Human Services has become increasingly concerned about the safe, appropriate, and effective use of psychotropic medications among children in foster care.” ‐‐ November 23, 2011

What do we know about the behavioral health needs of children and youth in Medicaid?

Estimates of Mental Health N eeds among Children and Youth • 1 in 5 children in the general population have a DSM diagnosable mental health disorder or were reported by parents to have an emotional or mental health need • 11% of youth have been diagnosed with a mental illness • Two ‐ thirds of youth who have a condition are not identified and do not receive mental health services • Half of all lifetime cases of mental illness or substance use disorders begin by age 14 Mental Health: A Report of the Surgeon General, 1999. United States. Public Health Service. Office of the Surgeon General Center for Mental Health Services National Institute of Mental Health. Behavioral Health, 2012, United States, Substance Abuse and Mental Health Services Administration. Lifetime Prevalence and Age-of-Onset Distributions of DSM IV Disorders in the National Comorbity Survey Replication, Kessler, R., Berglund, P., Demler, O., Jin, R., Merikangas, K., Walters, E, Archive of General Psychiatry, Volume 62, June 2005 pages 593-602.

Mental Health Needs among Children in Medicaid Estimates of mental health needs among children in Medicaid are higher than for the non ‐ Medicaid population Lack of access to Inadequate access needed services & to mental health & Adverse childhood supports, including Poverty substance use experiences prevention and disorder services for early intervention parents/caregivers services Howell, E. Access to Children’s Mental Health Services under Medicaid and SCHIP, Urban Institute, 2004.

What do we know about behavioral health service use among children and youth in Medicaid?

Children in Medicaid Using Behavioral Health Care • Represented under 10% of children enrolled in Medicaid, but accounted for an estimated 38% of total Medicaid child expenditures • 9.6% of Medicaid children used behavioral health care • 6.7% used behavioral health services (with or without psychotropic medications) • 5.8% used psychotropic medications (with or without behavioral health services) • 0.8% of Medicaid children used substance use disorder services S. Pires, K. Grimes, et al. Identifying Opportunities to Improve Children’s Behavioral Health Care: An Analysis of Medicaid Utilization and Expenditures . Center for Health Care Strategies, December 2013.

Highest Expenditure Services for Children in Medicaid Using Behavioral Health Services • Residential treatment and therapeutic group homes: o #1 cost driver in 2008 and 2005 – represents about 20% of all BH expenses for under 4% of children using BH care • Psychotropic medications: o 2 nd highest cost driver in 2008 o 3 rd highest in 2005 Pires, SA, Grimes, KE, Allen, KD, Gilmer, T, Mahadevan, RM. 2013. Faces of Medicaid: Examining Children’s Behavioral Health Service Utilization and Expenditures . Center for Health Care Strategies: Hamilton, NJ.

Psychotropic Medications Utilization and Expense Among Children in Medicaid • 5.8% of children in Medicaid (1.7 million) received psychotropic medications Only 51% of children prescribed psychotropic medications received • behavioral health services • Total Medicaid expense for child and adolescent psychotropic medication use in 2005 was $1.6 billion, with 42% of expense represented by antipsychotic use • Mean expense by aid category, was: o $934 per child, in foster care o $916 per child, for those with SSI o $475 per child, for children covered by TANF Pires, SA, Grimes, KE, Allen, KD, Gilmer, T, Mahadevan, RM. 2013. Faces of Medicaid: Examining Children’s Behavioral Health Service Utilization and Expenditures : Center for Health Care Strategies: Hamilton, NJ.

Distribution of Medication Use by Diagnosis Percent Distribution of Medication Type by Psychiatric Diagnosis ADHD Mood Anxiety COD DD Psychosis Other DX No DX Antipsychotics 24.6% 60.9% 41.0% 51.6% 63.5% 81.1% 53.6% 28.5% Mood Stabilizers 6.3% 23.3% 11.1% 15.6% 13.1% 21.7% 12.9% 8.0% Lithium 1.4% 8.0% 3.3% 4.1% 3.2% 8.6% 4.9% 1.3% Antidepressants 23.0% 62.9% 67.2% 42.1% 40.5% 52.1% 51.5% 49.4% ADHD/ stimulants 93.3% 48.0% 47.0% 65.3% 54.9% 42.8% 55.8% 49.4% Anxiety 1.8% 5.1% 9.1% 4.0% 9.4% 7.0% 6.5% 6.4% N = 1,686,387 (Medicaid enrolled children in 2005 with claims for psychotropic medication) Pires, SA, Grimes, KE, Allen, KD, Gilmer, T, Mahadevan, RM. 2013. Faces of Medicaid: Examining Children’s Behavioral Health Service Utilization and Expenditures : Center for Health Care Strategies: Hamilton, NJ.

Many Factors Contribute to Reliance on Psychotropic Medication • Legitimate need among the population • Inadequate screening and assessment/misdiagnosis including trauma Lack of access to non ‐ pharmacologic intervention including EBPs • • Too few child behavioral health specialists • Lack of coordination across providers and child ‐ serving agencies • Misaligned financial incentives • Aggressive/effective pharmaceutical marketing Limited clinical knowledge among child welfare case workers* • *Applies to children in foster care

How can we improve the appropriate use of psychotropic medications among children and youth in Medicaid?

Oversight and Monitoring Defined Oversight Monitoring • The administrative processes a • The process by which a system system has in place to ensure that ensures the care delivered to prescribing is appropriate, and individual children and youth is may be either prospective (e.g., within acceptable limits, and is prior authorization or second necessarily retrospective. opinion programs) or • This can be accomplished through retrospective. the regular review of utilization • Oversight is conducted by the reports generated from the system authorizing care and/or Medicaid claims system, or other payment, and focuses on the tracking mechanisms. prescribing practices of the individual provider or prescriber. Definitions proposed by K. Allen. Input solicited from Psychotropic Medication Quality Improvement Collaborative States .

State Policies: Prior Authorization • Prior Authorization: – The pre ‐ approval process that a prescriber must use in order for a beneficiary’s payer to cover the prescribed drugs. – Process varies between payers and even between different prescribed drugs under one payer. Some states limit approval of atypical antipsychotics to children with specific diagnoses. – 31 states use prior authorization for at least some children enrolled in Medicaid, the age requirement varies by state.

State Policies: Denial • Denial: – Some states deny the use of atypical antipsychotics for individuals under a certain age. The drug is not covered by the payer, with no exceptions. – 3 states that deny antipsychotic coverage for children under a certain age, with no exceptions. How Do States Monitor Atypical Antipsychotics Prescribed To Children? OPEN MINDS Market Intelligence Report

State Policies: Informed Consent • Informed Consent: – The process by which health care providers explain the consequences and benefits of a certain treatment or prescription drug in terms that can be easily understood by the patient. – 5 states use written informed consent for the general Medicaid population; at least 9 states require the use of written informed consent for the foster care population specifically. How Do States Monitor Atypical Antipsychotics Prescribed To Children? OPEN MINDS Market Intelligence Report

State Policies: Consultation Hotlines • Psychiatric Consultation Hotlines: – Some states focus on provider education and awareness before a drug is prescribed by offering free psychiatric consultation hotlines. – Consultation hotlines allow a physician/prescriber to consult on a child’s behavioral health issue and the best course of treatment. – 10 states fund psychiatric consultation hotlines for children. How Do States Monitor Atypical Antipsychotics Prescribed To Children? OPEN MINDS Market Intelligence Report